Protocol summary

Study aim
This study aims to compare the effectiveness of a 16-item Modified Olfactory Training protocol against classic training and a placebo for treating post-viral smell loss. It will measure improvements in odor identification, discrimination, and threshold to develop better rehabilitation strategies for patients.
Design
A single-center, randomized, single-blind, three-arm parallel-group controlled trial with a total sample size of 60 participants. Randomization will be computer-generated with allocation concealment, comparing modified olfactory training (16 scents), classic training (4 fixed scents), and placebo control groups over a 16-week intervention period.
Settings and conduct
A single-center, randomized, single-blind trial with 60 participants experiencing l smell loss. Participants are randomly assigned to classic training (4 fixed scents), or modified training (16 rotating scents). Olfactory performance, measured via Sniffin' Sticks test, is assessed at baseline and after a 16-week intervention.
Participants/Inclusion and exclusion criteria
Participants (n=60) with confirmed post-viral olfactory dysfunction. Inclusion requires confirmed smell loss and age 18-50, while exclusion criteria include nasal deformities, neurological/psychiatric conditions, tumors, and other factors that could interfere with the study.
Intervention groups
Group 1: Control (Placebo) 20 participants using odorless solvents Group 2: Classic Olfactory Training 20 participants using four fixed scents Group 3: Modified Olfactory Training 20 participants using rotating scents
Main outcome variables
The main findings of this study pertain to changes in olfactory performance, which are measured using the Sniffin' Sticks test. The primary outcome variables are the scores of this test, evaluated at baseline and after the 16-week intervention.

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20210414050971N1
Registration date: 2025-12-29, 1404/10/08
Registration timing: registered_while_recruiting

Last update: 2025-12-29, 1404/10/08
Update count: 0
Registration date
2025-12-29, 1404/10/08
Registrant information
Name
Nafiseh Alizadeh
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 6655 2828
Email address
nafiseh.alizadeh@gmail.com
Recruitment status
recruiting
Funding source
Expected recruitment start date
2025-07-14, 1404/04/23
Expected recruitment end date
2028-01-22, 1406/11/02
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Investigating the effects of 16-item olfactory training (Modified Olfactory Training) in improving olfactory disorders
Public title
Investigating the effects of olfactory training in improving olfactory disorders
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Confirmed olfactory dysfunction by the Sniffin’s Sticks test olfactory dysfunction Age range: 18 to 50 years
Exclusion criteria:
Severe nasal septum deviation Psychiatric disorders Pregnancy Sinusitis Nasal or brain tumors Alcohol consumption Nasal polyps Occupational exposure to unfavorable conditions (e.g., working in paint factories or with heavy metals) Congenital anosmia
Age
From 18 years old to 50 years old
Gender
Both
Phase
N/A
Groups that have been masked
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
Participants (n=60) who meet the inclusion criteria will be randomly assigned into three groups (20 patients per group): Group 1 (Control): No olfactory training / placebo kit. Group 2 (Classical Training): 16-week olfactory training with 4 fixed odorants. Group 3 (Modified Training): 16-week olfactory training with 4 different odorants each month. Randomization will be performed using a computer-generated random number table to ensure equal allocation to each group. Allocation concealment will be maintained by assigning codes to participants until group assignment is finalized.
Blinding (investigator's opinion)
Single blinded
Blinding description
The investigators who provide the training kits will be aware of the allocation due to the differences in kit content. The outcome assessor conducting the Sniffin’s Sticks test will remain blinded to the participants’ group allocation to ensure unbiased evaluation.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
research ethics committee of iran university of medical sciences
Street address
Floor 13, Block A, Ministry of Health & Medical Education Headquarters, Between Zarafashan & South Falamak, Qods Town, Tehran, Iran.
City
Tehran
Province
Tehran
Postal code
0
Approval date
2025-07-14, 1404/04/23
Ethics committee reference number
IR.IUMS.REC.1404.400

Health conditions studied

1

Description of health condition studied
The study investigates Post-Viral Olfactory Dysfunction (PVOD), a condition where a viral infection (like COVID-19, flu, or colds) damages the nasal olfactory cells, causing a reduced or complete loss of smell (hyposmia or anosmia).This condition has a severe impact on quality of life, posing safety risks (inability to smell gas leaks, smoke, or spoiled food) and causing psychological distress (depression, anxiety, social isolation) and nutritional issues.While always a problem, the COVID-19 pandemic has drastically increased the number of people suffering from persistent PVOD, creating a critical need for effective treatments, which this study aims to address.
ICD-10 code
G52.0
ICD-10 code description
Disorders of olfactory nerve

Primary outcomes

1

Description
Change in olfactory function scores (Threshold, Discrimination, and Identification; TDI score) measured by the Sniffin’s Sticks test from baseline to 16 weeks after intervention.
Timepoint
Baseline (T0): Measurement is taken before the start of the intervention.Endpoint (T1): Measurement is taken once, immediately after the completion of the 16-week intervention period.
Method of measurement
A total of 60 patients with post-viral olfactory dysfunction (confirmed by an olfactory test) will be selected and, after being informed about the study objectives and giving personal consent, will participate in the study. Patients will undergo the Sniffin’ Sticks olfactory test before and after olfactory training. This test includes: olfactory threshold, olfactory discrimination, and olfactory identification.Inclusion criteria: Olfactory dysfunction confirmed by the Sniffin’ Sticks test, post-viral olfactory dysfunction, and age between 18 and 50 years.Exclusion criteria: Severe nasal deviation, psychological disorders, pregnancy, sinusitis, tumor, alcohol consumption, nasal polyps, working in unfavorable conditions (e.g., in paint or heavy metal factories), congenital anosmia, or history of head trauma.In this study, patients are divided into three groups:Group 1: 20 participants serve as the control group and receive olfactory training with a solvent only (without any scent).Group 2: 20 participants form the classic treatment group and receive olfactory training for 16 weeks with four fixed essential oils. The training involves smelling each of the four oils (rose, lemon, eucalyptus, and thyme) twice daily, morning and evening, for 10 seconds each, with a 10-second interval between scents.Group 3: 20 participants form the modified treatment group and receive olfactory training for 16 weeks, with the difference that four different essential oils are provided each month. Other training conditions are the same as Group 2.Before and after the intervention, the Sniffin’ Sticks olfactory test is performed.The Sniffin’ Sticks test lasts 30–45 minutes and includes 16 pens, in which the pads contain the target scent instead of ink. The olfactory substance is presented at a concentration above the detection threshold. The extract is held 2 cm from the nostrils, and the patient sniffs for 2–3 seconds. The total TDI score is calculated by summing the olfactory threshold (T), discrimination (D), and identification (I) scores. After confirming olfactory dysfunction and identifying the type of disorder, the patient enters the study.

Secondary outcomes

empty

Intervention groups

1

Description
Control group: 20 people are the control group and receive olfactory training with a neutral odor (no essential oil).
Category
Treatment - Other

2

Description
Intervention group: 20 people are the classical therapy group and receive olfactory training over 16 weeks with four fixed extracts. The olfactory training involves the patient smelling each of the four extracts—rose, lemon, eucalyptus, and thyme—for 10 seconds, twice daily (morning and evening), for 16 weeks. There should be a 10-second interval between scents during which no fragrance is inhaled.
Category
Treatment - Other

3

Description
Intervention group: 20 people are the modified therapy group and undergo olfactory training over 16 weeks, with the difference that they receive four different extracts each month. However, all other training conditions remain the same as in Group 2
Category
Treatment - Other

Recruitment centers

1

Recruitment center
Name of recruitment center
Iran University of Medical Sciences
Full name of responsible person
Rafieh Alizadeh
Street address
ENT and Head & Neck Research Centere, Hazrat Rasoul Akram Hospital, IUMS
City
Tehran
Province
Tehran
Postal code
0
Phone
+98 912 091 5313
Email
alizadeh.r@iums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Dr.Majid Safa (Vice-Chancellor for Research, Iran University of Medical Sciences)
Street address
Shahid Hemmat Highway, Iran University of Medical Sciences, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
0
Phone
+98 912 091 5313
Email
alizadeh.r@iums.ac.ir
Web page address
https://vcr.iums.ac.ir/
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Rafieh Alizadeh
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Anatomy
Street address
ENT and Head & Neck Research Centere, Hazrat Rasoul Akram Hospital, IUMS
City
Tehran
Province
Tehran
Postal code
0
Phone
+98 912 091 5313
Email
alizadeh.r@iums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Rafieh Alizadeh
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Anatomy
Street address
ENT and Head & Neck Research Centere, Hazrat Rasoul Akram Hospital, IUMS
City
Tehran
Province
Tehran
Postal code
0
Phone
+98 912 091 5313
Email
alizadeh.r@iums.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Rafieh Alizadeh
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Anatomy
Street address
ENT and Head & Neck Research Centere, Hazrat Rasoul Akram Hospital, IUMS
City
Tehran
Province
Tehran
Postal code
0
Phone
+98 912 091 5313
Email
alizadeh.r@iums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
Investigating the effects of 16-item olfactory training (Modified Olfactory Training) in improving olfactory disorders". Details of Data to be Shared: Content: All collected de-identified IPD that underlies the results reported in the primary and secondary publications. Specific datasets include: Baseline Characteristics: Age, sex, duration of olfactory loss prior to study entry. Primary Outcome Data: Raw and calculated TDI scores (Threshold, Discrimination, Identification, Total) from the Sniffin' Sticks test at Baseline and Week 16. Group Allocation: The study group each participant was assigned to (Control, Classic OT, Modified OT). Adherence/Compliance Data: Metric of protocol adherence (e.g., percentage of training sessions completed, if collected). Data will be stripped of all direct identifiers: Name, initials, exact birth date, medical record number, contact information, and any other unique identifying details will be removed. A unique, random participant code will be used.
When the data will become available and for how long
The de-identified Individual Participant Data (IPD), study protocol, statistical analysis plan, and informed consent form will become publicly available no later than the publication date of the primary results manuscript in a peer-reviewed scientific journal. If required by the journal or funder, the data will be deposited at the time of manuscript submission, with the access link becoming active upon article publication.
To whom data/document is available
De-identified Individual Participant Data (IPD) and supporting documents will be made available to any legitimate researcher or analyst, regardless of their institutional affiliation, for the purpose of advancing scientific and public health knowledge. This explicitly includes: Academic Researchers: Researchers and students from universities and other academic institutions. Commercial or Industry Researchers: Researchers working within pharmaceutical, biotechnology, or medical device companies. Government and Public Health Researchers: Researchers from public health agencies, regulatory bodies, or government institutes. Independent Researchers: Qualified researchers not affiliated with a formal institution. Systematic Reviewers and Meta-Analysts: Individuals conducting evidence syntheses.
Under which criteria data/document could be used
Purpose: Requests must be for scientific research, such as meta-analysis, validation, or secondary analysis, aligned with ethical standards and the original informed consent. Mechanism: Requestors must submit a formal research proposal outlining objectives, methodology, and intended use. Proposals will be reviewed by a Data Access Committee (including the Principal Investigator and independent members). Conditions: Users must sign a Data Use Agreement prohibiting re-identification, commercial exploitation, or unethical use. Data will be provided securely after approval. Review Criteria: Proposals are evaluated for scientific merit, ethical compliance, feasibility, and alignment with participant consent.
From where data/document is obtainable
Contact Person: The first point of contact for all data access requests is the Principal Investigator (PI) of the study. Contact Information: Name: Dr. Rafieeh Alizadeh (رفیعه علیزاده) Affiliation: Independent Sensory Health Research Institute, Iran University of Medical Sciences Email: [PI's specific email address would be listed here, e.g., alizadeh.r@iums.ac.ir] Telephone: [+98 21 8670 2508] (University switchboard; request extension for the PI's office or department)
What processes are involved for a request to access data/document
Step-by-Step Process: Initial Inquiry Action: Email the Principal Investigator (PI) with a brief description of your research intent. Time: ~1 week for initial response and receipt of application forms. Formal Application Action: Submit a detailed research proposal and completed Data Access Request Form to the PI. Requirements: Include research objectives, analysis plan, needed variables, and team qualifications. Time: ~1-2 weeks for preparation and submission. Committee Review Action: The Data Access Committee (DAC) reviews the proposal for: Scientific merit and feasibility. Ethical alignment with original consent. Re-identification risks. Time: ~2-4 weeks for assessment and decision. Agreement Execution Action: If approved, sign a Data Use Agreement (DUA) prohibiting re-identification or commercial use. Time: ~1-2 weeks for signing and returning the DUA. Data Transfer Action: Data is shared via a secure repository or encrypted platform. Time: ~1 week for access provisioning.
Comments
Loading...